Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Medtronic
Harvard Business School
McKesson
Dow

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Andrographolide

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Andrographolide?

Andrographolide is an investigational drug.

There have been 7 clinical trials for Andrographolide. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Multiple Sclerosis, Bronchitis, and Acute Disease. The leading clinical trial sponsors are Universidad Austral de Chile, Jiangxi Qingfeng Pharmaceutical Co. Ltd., and University of Chile.

There are five US patents protecting this investigational drug and thirty-one international patents.

Recent Clinical Trials for Andrographolide
TitleSponsorPhase
HMPL004-6599 Phase I Dose-escalating StudyHutchison Medipharma LimitedPhase 1
HMPL004-6599 Phase I Dose-escalating StudyNestléPhase 1
HMPL004-6599 Phase I Dose-escalating StudyNutrition Science Partners LimitedPhase 1

See all Andrographolide clinical trials

Clinical Trial Summary for Andrographolide

Top disease conditions for Andrographolide
Top clinical trial sponsors for Andrographolide

See all Andrographolide clinical trials

US Patents for Andrographolide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Andrographolide   Start Trial Anticancer compounds: process for their preparation and pharmaceutical compositions containing them Dr. Reddy's Research Foundation (Hyderabad, IN)   Start Trial
Andrographolide   Start Trial Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them Dr. Reddy's Laboratories Limited (Andhra Pradesh, IN)   Start Trial
Andrographolide   Start Trial Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation for PPR-gamma receptors Herbal Powers Corporation (Bradenton, FL)   Start Trial
Andrographolide   Start Trial Andrographolide derivatives and use thereof in manufacture of medicaments Panorama Research Inc. (Sunnyvale, CA)   Start Trial
Andrographolide   Start Trial Anti-fatigue agents and oral compositions containing andrographolide as active ingredient Suntory Holdings Limited (Osaka-shi, Osaka, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Andrographolide

Drugname Country Document Number Estimated Expiration Related US Patent
Andrographolide Australia 5657001 1989-12-31   Start Trial
Andrographolide World Intellectual Property Organization (WIPO) 0185710 1989-12-31   Start Trial
Andrographolide Australia 5656801 1989-12-31   Start Trial
Andrographolide World Intellectual Property Organization (WIPO) 0185709 1989-12-31   Start Trial
Andrographolide Australia 2004315105 2024-02-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.